| Q3 FY 2026 Earnings Conference Call
Summary : Firstsource Solutions reported strong Q3FY26 results with double-digit revenue growth and margin expansion, driven by strategic deals, acquisitions, and a positive outlook for FY26.
Management Perspective positive : Management expressed pleasure with Q3 results, highlighting consistent double-digit growth, margin expansion, strong deal wins, and successful acquisitions. They raised FY26 guidance and expressed confidence in future growth trajectory and strategic priorities.
Concall Report Analysis & Insights
Business Overview
- Q3FY26 revenue grew 16.2% YoY to Rs 24.4 billion (US$274 million, up 10.2% YoY).
- Constant currency revenue growth was 10.6% YoY and 4.6% QoQ, including Pastdue Credit acquisition.
- EBIT margin expanded to 11.9%, up 80 basis points YoY and 40 basis points QoQ.
- Net profit, adjusted for exceptional items, was Rs 2 billion, a 26% YoY increase.
- Signed five large deals and added nine new logos, including five strategic ones.
Future Growth Prospects
- FY26 constant currency revenue growth guidance raised to 14.5-15.5% (including acquisitions).
- EBIT margin guidance for FY26 raised to 11.5-12%, with a long-term target of 14-15%.
- Deal pipeline remains robust, exceeding US$1 billion, with increased large deal wins.
- TeleMedik acquisition strengthens clinical and utilization management capabilities, expanding payer market presence.
- Expanding into new growth geographies like Canada and US retail/utilities markets.
Management Insights
- Q3 marks the seventh consecutive quarter of double-digit YoY revenue growth.
- Achieved fifth straight quarter of margin expansion, exceeding annual guidance.
- Strategic acquisitions (Pastdue Credit, TeleMedik) are integrating well and expanding capabilities.
- Focused on broad-basing client footprint and curating new growth engines.
- Confident in delivering sustainable, profitable, and industry-leading growth.
Signs of Skepticism
- Impact of government spending changes in healthcare is still early to assess fully.
- Potential credit card late payment fee cap is a proposal, its enforcement and impact are uncertain.
- Exact revenue impact of onshore to nearshore shift was not quantified.
- Q4 growth relies on an upward trajectory despite typical seasonality in some segments.
Risk Factors
- Healthcare segment faces margin pressure from unchanged Medicare Advantage rates.
- Proposed government cap on credit card late payment fees creates ambiguity for banks.
- Account rationalization in healthcare provider segment may impact short-term optical growth.
- Macroeconomic conditions and higher labor costs could influence client decisions.
Good To Know
- Headcount increased by 690 to 36,689, with 80% of gross additions in offshore/nearshore locations.
- Trailing 12-month attrition decreased to 27.4%, an improvement over eight quarters.
- Launched 'unBound' skills and talent platform to support internal mobility and skill development.
- Achieved an S&P Global Sustainable 1 ESG score of 87, ranking #1 in professional services.
- Declared an interim dividend of Rs 5.5 per share.
Key Drivers
- Strong deal pipeline over $1 billion.
- Acquisitions expand market reach.
- AI-driven solutions attract clients.
- Offshore shift improves cost structure.
Key Analyst Discussions
Competitive Environment
- Lower government spending in healthcare drives clients towards outsourcing and transformational programs.
- TeleMedik acquisition in Puerto Rico offers a structural cost advantage for US healthcare payers.
- The UnBPO™ approach is generating significant traction in the marketplace.
- Expanding into new markets like US retail and utilities leverages existing UK capabilities.
Market Trends & Consumer Behavior
- Unchanged Medicare Advantage rates add margin pressure on payers, increasing outsourcing demand.
- Mortgage business remains stable, but a significant refinance market impact requires rates below 5%.
- Proposed credit card late payment fee cap is a proposal; no immediate business impact is foreseen.
- Overall demand across all verticals is broad-based for the next 12 months.
Financial Highlights
- PDC acquisition added approximately 300 employees to the headcount.
- PDC acquisition amortization cost is estimated at GBP 2-2.5 million over four years.
- The steady-state effective tax rate is expected to be around 21% +/- 1%.
- Q3 performance was broadly in line with expectations, excluding planned tail account trimming.
- Management is comfortable with the 4% QoQ growth implied for Q4, supported by pipeline.
Product Composition
- The diverse portfolio, including utilities and retail, is a key growth driver.
- Over 50% of the company's business is now non-linear in construct.
- Different segments experience seasonal push and pulls throughout the year.
- Technology business typically sees a soft Q3 due to holiday period decisions.
Strategic Considerations
- Healthcare provider account rationalization targets low-margin accounts, aiming for margin improvement.
- Offshoring and nearshoring trend will continue, with 80% of gross hiring in these locations.
- Pastdue Credit was integrated for all of Q3FY26; TeleMedik will be integrated in Q4FY26.
- UK onshore headcount decreased by 40%, while South Africa headcount increased by 50%.